OmniActive Health Technologies has acquired ENovate Biolife

OmniActive Health Technologies has announced the acquisition of ENovate Biolife. Prior to this, the company had a partnership with ENovate in 2019 through a licensing agreement for its enXtra ingredient, which is branded Alpinia galanga extract (AGE) that supports mental alertness. The success of that agreement led to a global expansion of the agreement. As a result, enXtra has been commercialized by a number of premium brands worldwide.

“ENovate's approach to ingredients perfectly aligns with OmniActive’s mission of delivering proven products that make a meaningful difference in consumers’ lives,” said Sanjay Mariwala, founder and managing director of OmniActive in a press release. “ENovate has done a remarkable job bringing multiple standout ingredients to the market, including Muvz, RedNite, and the award-winning Oxyjun. We look forward to bringing these newly acquired ingredients to more brands and formulation partners looking to serve health-conscious consumers around the world.”

Muvs is a proprietary blend of Vitex negundo leaves and Zingiber officinale rhizome that has been shown in research to support the quality of life in people with back pain. RedNite is a branded beetroot extract that supports cognitive health, and Oxyjun is a proprietary, standardized aqueous extract of Terminalia arjuna bark that supports cardiovascular health.

“We are extremely proud of the strides we have made to help our loyal customers deliver products formulated with clinically backed ingredients to address consumer health and performance needs,” said Jayesh Chaudhary, founder and CEO of ENovate. “OmniActive’s comprehensive capabilities spanning across clinical research, R&D, regulatory, marketing and operations, along with global reach, position us well to elevate these ingredients even further.”